Literature DB >> 20199960

Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign.

Michael B Potter1, Ginny Gildengorin, Yinan Wang, May Wu, Lisa Kroon.   

Abstract

OBJECTIVE: To compare the effectiveness of two different pharmacy-based colorectal cancer screening (CRCS) interventions taking place during an annual influenza vaccination campaign.
DESIGN: Time-randomized clinical trial.
SETTING: San Francisco, CA, in late 2008. PARTICIPANTS: 133 adults aged 50 to 80 years visiting a pharmacy during an influenza vaccination campaign and also due for CRCS. INTERVENTION: On five dates, eligible patients were provided education and encouraged to obtain screening from their primary care clinician. On 17 dates, a home fecal immunochemical test (FIT) for CRCS was provided. A 16-item questionnaire was administered by phone 3 to 6 months after study enrollment. MAIN OUTCOME MEASURE: Self-reported CRCS activity, comparing CRCS completion rates for participants provided with the FIT versus those provided with education and encouragement to obtain screening from patients' primary care clinician.
RESULTS: 86 participants in the FIT arm and 28 the CRCS education arm were interviewed. Interviews revealed that 19.8% of the FIT group and 50% of the CRCS education group discussed CRCS with their primary care clinician (P = 0.002). Of these participants, 59.3% in the FIT arm and 14.8% in the CRCS education arm reported completing screening (P < 0.001). Of participants in the FIT group, 52.2% completed FIT dispensed to them by the investigators. Most participants in both groups reported interest in receiving CRCS education and home CRCS tests from pharmacists in the future.
CONCLUSION: Pharmacy patients are receptive to CRCS interventions delivered in community pharmacies. Providing FIT to eligible patients during a pharmacy-based influenza vaccination campaign increases screening rates more than CRCS education alone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199960     DOI: 10.1331/JAPhA.2010.09199

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  9 in total

1.  The prevalence and characteristics of dual PharmD/MPH programs offered at US colleges and schools of pharmacy.

Authors:  Justine S Gortney; Sheila Seed; Nancy Borja-Hart; Veronica Young; Lisa J Woodard; Dolores Nobles-Knight; David M Scott; James D Nash
Journal:  Am J Pharm Educ       Date:  2013-08-12       Impact factor: 2.047

2.  Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).

Authors:  B E Meyerson; P C Dinh; J D Agley; B J Hill; D N Motley; G A Carter; W Jayawardene; P T Ryder
Journal:  AIDS Behav       Date:  2019-07

3.  Achieving pharmacy-based public health: a call for public health engagement.

Authors:  Beth E Meyerson; Priscilla T Ryder; Carriann Richey-Smith
Journal:  Public Health Rep       Date:  2013 May-Jun       Impact factor: 2.792

4.  Evaluation of a pharmacogenetic educational toolkit for community pharmacists.

Authors:  Susanne B Haga; Rachel Mills; Jivan Moaddeb
Journal:  Pharmacogenomics       Date:  2016-08-17       Impact factor: 2.533

Review 5.  The community pharmacist's role in cancer screening and prevention.

Authors:  Anthony James Havlicek; Holly Mansell
Journal:  Can Pharm J (Ott)       Date:  2016-07-29

6.  Assessing the Perception of Pharmacy Students on Launching a Doctor of Pharmacy/Master of Public Health Dual Degree Program in Saudi Arabia: A Multi-Institutional Cross-Sectional Study.

Authors:  Hisham A Badreldin; Khalid Bin Saleh; Aisha F Badr; Abdullah Alhifany; Shuroug A Alowais; Sumaya N Almohareb; Nada Alsuhebany; Abdulmajeed Alshehri; Mohammed Alzahrani; Anas Aldwsari; Ohoud Aljuhani; Ghazwa B Korayem; Khalid Al Sulaiman; Allulu Alturki; Hayfa Alhaidal; Yazeed Ghawaa
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

7.  Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.

Authors:  Alison T Brenner; Jewels Rhode; Jeff Y Yang; Dana Baker; Rebecca Drechsel; Marcus Plescia; Daniel S Reuland; Tom Wroth; Stephanie B Wheeler
Journal:  Cancer       Date:  2018-07-13       Impact factor: 6.860

8.  Widening the scope for early cancer detection: identification of alarm symptoms by community pharmacies.

Authors:  Jay Badenhorst; Adam Todd; Laura Lindsey; Jonathan Ling; Andy Husband
Journal:  Int J Clin Pharm       Date:  2015-02-19

Review 9.  Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).

Authors:  James E Allison; Callum G Fraser; Stephen P Halloran; Graeme P Young
Journal:  Gut Liver       Date:  2014-03-11       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.